P

Pura Vida Investments

27 employees

Pura Vida Investments is a healthcare-focused investment vehicle specialized in private equity investments.

Investor insights

Sectors invested in

Biotechnology22
Health Care20
Medical Device12
Medical12
Wellness6
Therapeutics6
Life Science5
Health Diagnostics5
Medical Devices5
Cardiology4
LAP Regulation4
Heart Failure4
Biopharma3
Pharmacy3
Technology3
Engineering3
Professional Services3
Diabetes2
Pharmaceutical2
the iLet Bionic Pancreas2

Funding rounds participated in

$76M sweet spot round size

Most of their 31 investments are in rounds between $37M and $104M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Financial Services
Healthcare
Long/Short
Hedge Fund

Date founded

2012

Investments made

B

Beta Bionics raised $100M on August 30, 2023

Investors: Sands Capital Management, Farallon Capital Management, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners, Omega Funds and Pura Vida Investments

M

Monogram Health raised $375M on January 9, 2023

Investors: Cigna Ventures, CVS Health, Memorial Hermann Health System, Norwest Venture Partners, Frist Cressey Ventures, Heritage Group, TPG Global, Humana and Pura Vida Investments

U

Undisclosed raised $75M on September 30, 2022

Investors: Laurion Capital Management LP, Perceptive Advisors, RA Capital Management, L.P., The Invus Group, CaaS Capital Management and Pura Vida Investments

S

Sonendo®, Inc. raised $63M on September 23, 2022

Investors: Driehaus Capital Management LLC, First Light Asset Management and Pura Vida Investments

L

Lyra Therapeutics raised $101M on April 8, 2022

Investors: Perceptive Advisors, Samsara BioCapital and Pura Vida Investments

B

Beta Bionics raised $57M on February 17, 2022

Investors: Soleus Capital Management, L.P., Novo Nordisk Ltd, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Farallon Capital Management, Perceptive Advisors and Pura Vida Investments

N

Nalu Medical, Inc. raised $104M on February 17, 2022

Investors: Gilde Healthcare, Aperture Venture Partners, Decheng Capital, Advent Life Sciences, Longitude Capital, MVM Partners, Endeavour Vision and Pura Vida Investments

G

GreenLight Biosciences, Inc. raised $126M on February 3, 2022

Investors: Xeraya Capital, S2G Ventures, Morningside Venture Capital 晨兴资本, Spruce Capital Partners, LLC and Pura Vida Investments

M

Metagenomi raised $175M on January 25, 2022

Investors: Partner Fund Management, Millennium Partners, Surveyor Capital, YAYA Capital, Novo Holdings, Leaps by Bayer, Moderna, Marshall Wace, RA Capital Management, L.P. and Pura Vida Investments

V

V-Wave raised $98M on December 16, 2021

Investors: Pontifax Venture Capital, Triventures, Aperture Venture Partners, BRM Group, Quark Venture, ISF Israel Secondary Fund, Endeavour Vision and Pura Vida Investments

FAQ